545 related articles for article (PubMed ID: 28735972)
21. Advances in new target molecules against schistosomiasis: A comprehensive discussion of physiological structure and nutrient intake.
Zhu P; Wu K; Zhang C; Batool SS; Li A; Yu Z; Huang J
PLoS Pathog; 2023 Jul; 19(7):e1011498. PubMed ID: 37498810
[TBL] [Abstract][Full Text] [Related]
22. Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel.
Kasinathan RS; Sharma LK; Cunningham C; Webb TR; Greenberg RM
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3265. PubMed ID: 25330312
[TBL] [Abstract][Full Text] [Related]
23. Acetylcholinesterase and Nicotinic Acetylcholine Receptors in Schistosomes and Other Parasitic Helminths.
You H; Liu C; Du X; McManus DP
Molecules; 2017 Sep; 22(9):. PubMed ID: 28906438
[TBL] [Abstract][Full Text] [Related]
24. Schistosome transcriptomes: new insights into the parasite and schistosomiasis.
Hu W; Brindley PJ; McManus DP; Feng Z; Han ZG
Trends Mol Med; 2004 May; 10(5):217-25. PubMed ID: 15121048
[TBL] [Abstract][Full Text] [Related]
25. Mefloquine, a new type of compound against schistosomes and other helminthes in experimental studies.
Xiao SH
Parasitol Res; 2013 Nov; 112(11):3723-40. PubMed ID: 23979493
[TBL] [Abstract][Full Text] [Related]
26. Immunological Considerations for
Driciru E; Koopman JPR; Cose S; Siddiqui AA; Yazdanbakhsh M; Elliott AM; Roestenberg M
Front Immunol; 2021; 12():635985. PubMed ID: 33746974
[TBL] [Abstract][Full Text] [Related]
27. Recent Advances in the Synthesis of Antischistosomal Drugs and Agents.
Liu LX; Li-Li J; Qiong C; Xiao-Lin F
Mini Rev Med Chem; 2017; 17(5):467-484. PubMed ID: 24251801
[TBL] [Abstract][Full Text] [Related]
28. Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs.
Doenhoff MJ; Hagan P; Cioli D; Southgate V; Pica-Mattoccia L; Botros S; Coles G; Tchuem Tchuenté LA; Mbaye A; Engels D
Parasitology; 2009 Nov; 136(13):1825-35. PubMed ID: 19281637
[TBL] [Abstract][Full Text] [Related]
29. Antiparasitic activity of piplartine (piperlongumine) in a mouse model of schistosomiasis.
Mengarda AC; Mendonça PS; Morais CS; Cogo RM; Mazloum SF; Salvadori MC; Teixeira FS; Morais TR; Antar GM; Lago JHG; Moraes J
Acta Trop; 2020 May; 205():105350. PubMed ID: 31962096
[TBL] [Abstract][Full Text] [Related]
30. Schistosomiasis control: keep taking the tablets.
Hagan P; Appleton CC; Coles GC; Kusel JR; Tchuem-Tchuenté LA
Trends Parasitol; 2004 Feb; 20(2):92-7. PubMed ID: 14747023
[TBL] [Abstract][Full Text] [Related]
31. Schistosomiasis control: praziquantel forever?
Cioli D; Pica-Mattoccia L; Basso A; Guidi A
Mol Biochem Parasitol; 2014 Jun; 195(1):23-9. PubMed ID: 24955523
[TBL] [Abstract][Full Text] [Related]
32. Praziquantel, a new board-spectrum antischistosomal agent.
Gönnert R; Andrews P
Z Parasitenkd; 1977 Jul; 52(2):129-50. PubMed ID: 410178
[TBL] [Abstract][Full Text] [Related]
33. [Advances in research on antischistosomal drugs].
Qiu SJ; Xia CM
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2011 Jun; 23(3):337-9. PubMed ID: 22164510
[TBL] [Abstract][Full Text] [Related]
34. The potential of artemether for the control of schistosomiasis.
Utzinger J; Xiao S; N'Goran EK; Bergquist R; Tanner M
Int J Parasitol; 2001 Dec; 31(14):1549-62. PubMed ID: 11730781
[TBL] [Abstract][Full Text] [Related]
35. Protein kinases as potential targets for novel anti-schistosomal strategies.
Beckmann S; Leutner S; Gouignard N; Dissous C; Grevelding CG
Curr Pharm Des; 2012; 18(24):3579-94. PubMed ID: 22607148
[TBL] [Abstract][Full Text] [Related]
36. From dithiocarbamates to branched dithiocarbazates: Compounds with potent antischistosomal activity.
Gallinger TL; Obermann W; Lange-Grünweller K; Schmidt N; Haeberlein S; Grünweller A; Grevelding CG; Schlitzer M
Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200491. PubMed ID: 36482264
[TBL] [Abstract][Full Text] [Related]
37. Pumping iron: a potential target for novel therapeutics against schistosomes.
Glanfield A; McManus DP; Anderson GJ; Jones MK
Trends Parasitol; 2007 Dec; 23(12):583-8. PubMed ID: 17962074
[TBL] [Abstract][Full Text] [Related]
38. Praziquantel derivatives with antischistosomal activity: aromatic ring modification.
Wang ZX; Chen JL; Qiao C
Chem Biol Drug Des; 2013 Aug; 82(2):216-25. PubMed ID: 23617439
[TBL] [Abstract][Full Text] [Related]
39. Artemether, an effective new agent for chemoprophylaxis against shistosomiasis in China: its in vivo effect on the biochemical metabolism of the Asian schistosome.
Shuhua X; Hotez PJ; Tanner M
Southeast Asian J Trop Med Public Health; 2000 Dec; 31(4):724-32. PubMed ID: 11414420
[TBL] [Abstract][Full Text] [Related]
40. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30 years' experience.
Chen MG
Acta Trop; 2005; 96(2-3):168-76. PubMed ID: 16125657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
